Today’s issue of WorkCompRecap features the continuation of our “Leaders Speak” series with the second installment from Dr. William Hopper, CMO of MediCall.
In his article, Dr. Hopper provides his perspective on what is quickly becoming a “hot-button” issue in the industry: the increased use of controlled substances in the course of patient pain management- which not only has ramifications for Work Comp costs (as a recent NCCI study pointed out), but for patient safety as well…
You can read Dr. Hopper’s new article at WorkCompWire by clicking here.
In case you missed last week’s post by Dr. Hopper on Utilization Management, you can read it by clicking here.
Many thanks to Dr. Hopper for his contribution to our Leaders Speak series!
Stay tuned as we continue to bring you great content from more Leaders in Work Comp…